Host variations in SARS-CoV-2 infection


Altiok D., Savci E. Z. , Ozkara B., Alkan K., Namdar D. S. , Tuncer G., ...More

TURKISH JOURNAL OF BIOLOGY, vol.45, no.4, pp.404-424, 2021 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Review
  • Volume: 45 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.3906/biy-2104-67
  • Title of Journal : TURKISH JOURNAL OF BIOLOGY
  • Page Numbers: pp.404-424
  • Keywords: Angiotensin-converting enzyme 2 (ACE2), host genetics, polymorphisms, SARS-CoV-2, toll-like receptors (TLR), transmembrane serine protease 2 (TMPRSS2), ACUTE RESPIRATORY SYNDROME, SARS-CORONAVIRUS PATHOGENESIS, DNA METHYLATION, PROSTATE-CANCER, PROMOTER POLYMORPHISM, GENE POLYMORPHISMS, BLOOD-GROUP, ACE2, SUSCEPTIBILITY, RECEPTOR

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the "Coronavirus Disease of 2019 (COVID-19)", and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors -e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.